Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Net Income towards Common Stockholders (2020 - 2026)

NeuroPace has reported Net Income towards Common Stockholders over the past 7 years, most recently at -$6.5 million for Q1 2026.

  • For Q1 2026, Net Income towards Common Stockholders changed 0.26% year-over-year to -$6.5 million; the TTM value through Mar 2026 reached -$21.0 million, up 15.94%, while the annual FY2025 figure was -$21.0 million, 23.56% up from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 was -$6.5 million at NeuroPace, down from -$2.7 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$2.7 million in Q4 2025 and troughed at -$12.6 million in Q2 2022.
  • A 5-year average of -$7.9 million and a median of -$7.6 million in 2024 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 101.12% in 2022 and later skyrocketed 47.15% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$11.0 million in 2022, then surged by 41.23% to -$6.5 million in 2023, then increased by 20.12% to -$5.2 million in 2024, then skyrocketed by 47.15% to -$2.7 million in 2025, then tumbled by 139.06% to -$6.5 million in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for NPCE at -$6.5 million in Q1 2026, -$2.7 million in Q4 2025, and -$3.6 million in Q3 2025.